The latest announcement is out from Singular Health Group Ltd ( (AU:SHG) ).
Singular Health Group Ltd has successfully completed several strategic and technical milestones in the March 2025 quarter, including the completion of a technical proof of concept with Provider Network Solutions (PNS) and the development of the 3Dicom Gateway. These achievements have accelerated the company’s progression to a commercial pilot phase with PNS, strengthening their relationship and positioning Singular Health for commercialization opportunities in the U.S. The company has also secured over $965k in funding, enhancing its financial position and readiness for the upcoming U.S. pilot program. Additionally, Singular Health has engaged with investors through targeted roadshows, attracting interest from institutional investors and reinforcing its commitment to improving medical imaging accessibility.
More about Singular Health Group Ltd
Singular Health Group Ltd operates in the medical imaging industry, focusing on the development and commercialization of the 3Dicom platform. This platform provides real-time, browser-based imaging access and sharing across healthcare networks, aiming to improve interoperability and accessibility in medical imaging. The company is primarily targeting the U.S. Managed Service Organizations (MSOs) market.
Average Trading Volume: 639,529
Technical Sentiment Signal: Sell
Current Market Cap: A$59.81M
Find detailed analytics on SHG stock on TipRanks’ Stock Analysis page.